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Abstract: Pathogens frequently rely on lectins for adhesion and 
cellular entry into the host.  Since these interactions typically result 
from multimeric binding of lectins to cell surface glycans, novel 
therapeutic strategies are being developed with the use of 
glycomimetics as competitors of such interactions. Herein we study 
the benefit of nucleic acid-based oligomeric assemblies with PNA-
fucose conjugates. We demonstrate that the interactions of a lectin 
with epithelial cells can be inhibited with conjugates that do not form 
stable assemblies in solution but benefit from the cooperativity of 
ligand-protein interactions and PNA hybridization to achieve high 
affinity. A dynamic dimeric assembly fully blocked the binding of the 
fucose-binding lectin BambL of Burkholderia ambifaria, a pathogenic 
bacterium, to epithelial cells with an efficiency of more than 700 fold 
compared to L-fucose. 
The role of multivalent interactions at cellular interfaces is well 
recognized.[1] Frequently, these interactions involve cell surface 
glycans which are specifically recognized by protein receptors 
such as lectins. Such interactions are generally of low affinities 
but, a high overall avidity is achieved through mutivalency. 
Pathogens frequently harness the specific recognition of host 
epithelial glycans for adhesion and infection with multivalent 
lectins[2-3], and inhibition of these interactions by competition with 
soluble glycocompounds represents a promising therapeutic 
avenue.[4] Herein, we investigated the gain of affinity achieved 
with nucleic acid-based assemblies oligomerizing L-fucose, and 
we demonstrate that the hybridization of dynamic fucose 
assembly operates cooperatively with ligand binding.  
 The Burkholderia cepacia complex is a group of closely 
related bacteria that cause lung infections in 
immunocompromised patients as well as in patients with 
granulomatous disease or cystic fibrosis.[5]   Burkholderia 
ambifaria lectin (BambL) and Ralstonia solanacearum lectin 
(RSL) are bacterial lectins that share a six-bladed beta-propeller 
fold formed by trimerization of monomers carrying two fucose-
binding sites, resulting in six fucose binding sites on the same 
face (Figure 1).[5-6] It has been shown that the interaction of RSL 
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Figure 1. Space filling and ribbon representation of RSL crystal structure 
complexed with α-methyl-L-fucoside represented as wire frame (PDB code 
2BT9). Blue arrows indicate the  20 Å through-space distance between the 
binding sites. RSL: Ralstonia solanacearum lectin. 
          
 
 
 
 
with fucosylated epitopes such as histo-blood group 
oligosaccharides exposed from glycolipids is sufficient to induce 
membrane invaginations in giant liposomes.[7-8]  Furthermore, 
oligomeric interactions are important for this invagination, since 
mutated lectins bearing only three fucose binding sites (e.g. R17A 
mutant) were also interacting with liposomes but failed to yield 
invagination.  Based on the interest in using nucleic acid 
hybridization of glycan-PNA conjugates (PNA: peptide nucleic 
acid)[9-16] to tailor assemblies that can bridge multiple binding sites 
in target proteins, we sought to 
evaluate the benefit of oligomeric 
assemblies for RSL and ultimately, to 
outcompete the interaction of such 
lectins with epithelial cells.  
 We began our investigation 
with RSL, designing a fucose ligand 
flanked by two 8-mer PNA (Figure 2). 
Using the appropriate complementary 
sequences, the fucose ligand can be 
oligomerized incrementally to a cyclic 
hexamer that would form a ring around 
the protein. The 8-mer PNA duplex 
stretches over 34 Å with a small 
curvature (though-space distance: 
PDB ID 3PA0)[17] thus yielding a 
hexagone with a perimeter of 204 Å 
which was deemed sufficiently large to 
fit the protein. The fucose ligand is 
linked to each side of the PNA with a 
10 Å flexible PEG spacer that leave 
some plasticity to fit the multivalent 
interaction. The 8-mer PNA have Tm > 
60 °C thus yielding stable assemblies 
at room temperature. The affinities of 
the different assemblies were 
measured by surface plasmon 
resonance (SPR) using a chip with low 
protein loading to avoid artifact from 
assemblies bridging two proteins. The 
control L-fucose-triazole conjugate 
(Fuc-triazole, Figure 1) has an affinity 
for RSL of approx. 2 µM, which is in the 
same range that the one previously 
reported for fucose.[6]  The presence of 
PNA on both sides of fucose increases 
the affinity for the lectin by one order 
of magnitude compared to the Fuc-
triazole control compound resulting in 
a KD of 362 nM, however, the PNA 
duplex lacking fucose did not show 
measurable affinity to the lectin. As 
shown in Figure 2, a significant gain in 
affinity is obtained in the progression 
from monomeric ligand with flanking 
double strand PNAs (362 nM) to the 
dimeric one (3.3 nM). This gain in 
affinity is consistent with the chelate 
effect of divalent interactions and 
confirmed that the 8-mer PNA with the 
flexible PEG linker is able to bridge two binding sites. However, 
progression to higher order oligomers only brought small 
incremental benefit (3 nM for the trimer, 1 nM for the tetramer, 0.9 
nM for the pentamer and 0.5 nM for the cyclic hexamer). 
Comparison of SPR sensorgrams obtained with monomeric and 
hexameric compounds is displayed in Figure 2 (See figure S1 for 
complete set of sensorgrams), illustrating the strong gain in 
affinity observed for oligomers. Enthalpy-entropy compensations 
have frequently been attributed to diminishing return in affinity 
Figure 2. A: Structure of the PNA-glycan adduct (top, PNA color denotes self-complementary) and SPR-measured KD for 
the assemblies. B: SPR sensorgrams for Fuc-triazole injected on RSL chips with concentrations starting at 3.33 µM and 
diluted by 3-fold at each step. C: Same experiments with the assembly produced from the mixture of compound 1 and 2 
forming a dimer (starting concentration 1 µM). D: Same with compounds 1 to 6 that form hexavalent assembly (starting 
concentration 0.1 µM). In all cases the bottom line corresponds to control injection of buffer.  The binding kinetics of the 
experiments were too fast (Fuc-triazol) or too complex (multivalent) to evaluate dissociation constants and steady-state 
analysis was performed instead. PNA: Peptide nucleic acid; RSL: Ralstonia solanacearum lectin; SPR: surface plasmon 
resonance. 
          
 
 
 
 
gain with higher order oligomeric interactions. Nonetheless, the 
sub-nanomolar affinity for the hexameric assembly remains 
notable considering that fucose ligand by itself has an affinity of 
2200 nM (i.e. >1000 fold gain in affinity).   
 We next asked if the significant gain in affinity observed 
for the static dimeric assembly could be achieved with shorter 
PNA that would not form stable duplexes in solution but only in 
the presence of the lectin through the cooperative interaction of 
the PNA duplex and the ligand-target interactions (Figure 3). To 
this end, we prepared the same fucose ligand with self-
complementary palindromic 4-mer PNA using two different 
sequences having different duplex stabilities (7a: TTAA: KD = 13 
μM, Tm <15 °C at 2 μM; 7b: GGCC: KD = 3.8 μM, Tm = 23 °C at 
2 μM; Figure S2-3).  Thus at concentrations below 1 μM, the 
ligands 7a and 7b are predominantly in the dissociated 
monomeric form. However, the duplex should be stabilized by the 
high effective concentration of the PNA at the surface of the lectin 
and the lectin binding should be enhanced through the chelate 
effect of the hybridized PNA. As shown in Figure 3, while the 
fucose ligand has an affinity of 2.2 μM, ligand 7a has an affinity of 
83 nM whereas ligand 7b has an affinity of 22 nM. When 
comparing the dissociation phase in the SPR sensorgrams, the 
fucose triazole adduct lacking the PNA has a very fast off-rate (koff 
= 2 x 10-1 s-1, Figure 2B), while the assembly arising from 7b 
dissociates much slower (koff = 5 x 10-4 s-1 , Figure 3 bottom). We 
therefore observe a clear increase in the residence time at 
                 
                    
Figure 3. Top:  Schematic representation of dynamic fucose dimer interacting with RSL; structure of compound 7-9 and affinities for assemblies prepared from 
7a and 7b. Bottom: SPR sensorgrams for compound 7b injected on RSL chips with concentrations starting at 6 µM and diluted by 3-fold at each step and 
derivation of dissociation constant from steady state analysis. PNA: Peptide nucleic acid; RSL: Ralstonia solanacearum lectin; SPR: surface plasmon resonance. 
          
 
 
 
 
concentrations well below duplex formation with a very slow 
dissociation phase that is characteristic of multivalent 
interactions. As further controls, we prepared the equivalent of 
compound 7b with a glucose instead of fucose (8) or omitting 
conjugation with a carbohydrate (9).  Neither of these controls had 
measurable affinities for the lectin (RSL).  To further assess the 
cooperative dynamic assembly of 7b, we performed the SPR 
measurements of 7b binding to RSL in the presence of increasing 
amount of control 9 which can compete for hybridization (up to 5 
equivalents).  The presence of control 9 had no impact on the 
affinity of 7b at stoichiometric amount (at this concentration, the 
probability of a 7b dimer from random hybridization is 25%; Figure 
S1).  At higher concentration (2.5 and 5 equivalents), the binding 
curves were slightly altered due to non-specific binding of 9 in the 
control channel, however, the same slow dissociation was 
observed as in the binding of 7b alone (at 5 equivalent of 9, the 
statistical probability of a 7b dimer is 2.7%) suggesting a self-
sorting of 7b dimer on the protein. The dramatic gain in affinity 
observed the dynamic assemblies of 7a or 7b as well as the lack 
of influence of 9 that can compete for hybridization can only be 
rationalized by the cooperativity of PNA hybridization and lectin 
interaction wherein the rebinding of ligand in the dimeric chelate 
is faster than PNA-duplex dissociation and likewise, duplex 
formation at the protein surface is faster than koff of the fucose 
ligand.  
 We then investigated the efficacy of the more potent 
assembly 7b to block binding of BambL to H1299 lung epithelial 
cells. For this purpose, we prepared both anomeric configurations 
of the fucose linked to the PNA. As shown in Figure 4, assemblies 
arising from both anomeric configurations were competent in 
inhibiting BambL binding to epithelial cells in a dose-dependent 
manner with an IC50 of 0.56 μM and 0.94 μM for the β-anomer and 
α-anomer of fucose, respectively.  Impressively, assembly 7b (β-
anomer) was 723-fold more effective than the fucose alone.  
Assays with the Fuc-triazole lacking the PNA did not show any 
activity at concentrations up to 100 μM and did not reach complete 
inhibition at the highest tested concentration (1 mM,  Figure S4).  
The gain of efficacy observed in this assay with the dynamic 
assemblies concurs with affinity measurements on RSL. It should 
be noted that the assays were carried out at a RSL concentration 
of 178 nM with a capacity to bind up to 1 μM of fucose ligand. 
While occupancy of the six binding sites is not necessary for 
adhesion inhibition, the IC50 measurement points to the fact that 
the inhibition is achieved with nearly stoichiometric quantities of 
ligands relatively to the lectin. Furthermore, these cellular assays 
were performed at 37 °C, which further displaces the equilibrium 
away from duplex formation.  The fact that assemblies 7b were 
more efficacious than the ligand alone at this temperature 
indicates that the cooperativity between ligand binding and duplex 
formation is still operative. 
 Multivalency plays a major role in biological processes 
and is omnipresent in the interaction of pathogenic 
microorganisms with their host. The search for high-affinity 
ligands that can inhibit these interactions has predominantly 
focused on oligomeric, polymeric and dendritic scaffolds 
functionalized with multiple ligand copies.[4, 18] To the best of our 
knowledge, this is the first example that demonstrates that such 
interactions can be inhibited with dynamic supramolecular 
assemblies in a cellular context. While dynamic combinatorial 
chemistry has been investigated for drug discovery and receptors 
using reversible covalent chemistry,[19-20] the use of hybridization 
can be tuned to yield the benefit of a cooperativity between the 
ligand pairing through base pairing and chelate effect of the 
ligand’s interactions with the target that is not achievable with 
covalent dynamic assemblies. This concept has inspired elegant 
studies to pair DNA- or PNA-encoded organic fragments for drug 
discovery.[21-26] In the present case, the dynamic assembly was 
723-fold more effective than the L-fucose alone in a cell-based 
assay. Many other pathogenic bacteria (e.g. P. aeruginosa via 
LecA or LecB, or uropathogenic E. coli via FimH) and bacterial 
products (e.g. Shiga toxin) that interact with host cell 
glycoreceptors could be in principle cleared by dynamic 
cooperative glycan assembly.  
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Figure 4. Inhibition of BambL binding to H1299 lung epithelial cells.  Left: 
dynamic assembly arising from 7b with the fucose α-L-fucose conjugate; 
Middle: dynamic assembly arising from 7b with the fucose β-L-fucose 
conjugate; Right: L-Fucose (corresponding bar charts with error bars are 
provided in Figure S4). BambL: Burkholderia ambifaria lectin 
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